Log in


-0.07 (-0.81 %)
(As of 07/8/2020 04:00 PM ET)
Today's Range
Now: $8.60
50-Day Range
MA: $8.28
52-Week Range
Now: $8.60
Volume1,500 shs
Average Volume5,636 shs
Market Capitalization$3.93 billion
P/E Ratio8.60
Dividend YieldN/A
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty, branded, and generic pharmaceutical products worldwide. The company offers various oral solid dose, liquids, semi-solids, steriles, biogicals, active pharmaceutical ingredients, and infant nutritional products. It also provides various therapeutic products, including anaesthetics; and injectable anticoagulants comprising orgaran for the treatment of HIT under the Thrombosis brand. In addition, the company offers oncology, endocrinology, and women's health products, as well as consumer healthcare products. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.82 out of 5 stars

Industry, Sector and Symbol

Industry Private households
Previous SymbolNASDAQ:APNHY



Sales & Book Value

Annual Sales$2.74 billion
Cash Flow$1.18 per share
Book Value$8.38 per share



Market Cap$3.93 billion
Next Earnings Date9/9/2020 (Estimated)
OptionableNot Optionable

Receive APNHY News and Ratings via Email

Sign-up to receive the latest news and ratings for APNHY and its competitors with MarketBeat's FREE daily newsletter.


How has ASPEN PHARMACAR/ADR's stock been impacted by COVID-19 (Coronavirus)?

ASPEN PHARMACAR/ADR's stock was trading at $6.75 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, APNHY shares have increased by 27.4% and is now trading at $8.60. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of ASPEN PHARMACAR/ADR?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ASPEN PHARMACAR/ADR in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for ASPEN PHARMACAR/ADR.

When is ASPEN PHARMACAR/ADR's next earnings date?

ASPEN PHARMACAR/ADR is scheduled to release its next quarterly earnings announcement on Wednesday, September 9th 2020. View our earnings forecast for ASPEN PHARMACAR/ADR.

Has ASPEN PHARMACAR/ADR been receiving favorable news coverage?

News headlines about APNHY stock have been trending negative recently, according to InfoTrie Sentiment. InfoTrie rates the sentiment of media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. ASPEN PHARMACAR/ADR earned a media sentiment score of -2.1 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View the latest news about ASPEN PHARMACAR/ADR.

Who are some of ASPEN PHARMACAR/ADR's key competitors?

Who are ASPEN PHARMACAR/ADR's key executives?

ASPEN PHARMACAR/ADR's management team includes the following people:
  • Mr. Stephen Bradley Saad, Group CEO & Exec. Director (Age 55)
  • Mr. Michael Guy Attridge, Deputy Group Chief Exec. & Exec. Director (Age 58)
  • Mr. Sean M. Capazorio, Group Fin. Officer (Age 52)
  • Ms. Lorraine Hill, Group Operating Officer (Age 55)
  • Mr. Riaan Verster BProc, LLM, LLB, ACIS, Company Sec., Group Governance Officer & Group Compliance Officer (Age 43)

What is ASPEN PHARMACAR/ADR's stock symbol?

ASPEN PHARMACAR/ADR trades on the OTCMKTS under the ticker symbol "APNHY."

How do I buy shares of ASPEN PHARMACAR/ADR?

Shares of APNHY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is ASPEN PHARMACAR/ADR's stock price today?

One share of APNHY stock can currently be purchased for approximately $8.60.

How big of a company is ASPEN PHARMACAR/ADR?

ASPEN PHARMACAR/ADR has a market capitalization of $3.93 billion and generates $2.74 billion in revenue each year. The company earns $455.64 million in net income (profit) each year or $1.00 on an earnings per share basis. ASPEN PHARMACAR/ADR employs 10,000 workers across the globe.

What is ASPEN PHARMACAR/ADR's official website?

The official website for ASPEN PHARMACAR/ADR is www.aspenpharma.com.

How can I contact ASPEN PHARMACAR/ADR?

ASPEN PHARMACAR/ADR's mailing address is 9 Rydall Vale Park Douglas Saunders Drive La Lucia Ridge, Durban T3, 4051. The company can be reached via phone at 27-31-580-8600.

This page was last updated on 7/9/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.